Sopharma AD SPH.WA Stock
Sopharma AD Price Chart
Sopharma AD SPH.WA Financial and Trading Overview
Sopharma AD stock price | 13.4 PLN |
Previous Close | 17 PLN |
Open | 15.3 PLN |
Bid | 14.2 PLN x N/A |
Ask | 15 PLN x N/A |
Day's Range | 15.3 - 15.3 PLN |
52 Week Range | 8.85 - 18.8 PLN |
Volume | 96 PLN |
Avg. Volume | 583 PLN |
Market Cap | 1.86B PLN |
Beta (5Y Monthly) | 0.092465 |
PE Ratio (TTM) | 8.315217 |
EPS (TTM) | 1.48 PLN |
Forward Dividend & Yield | 1.38 (7.35%) |
Ex-Dividend Date | June 15, 2023 |
1y Target Est | 4.2 PLN |
SPH.WA Valuation Measures
Enterprise Value | 2.24B PLN |
Trailing P/E | 8.315217 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Sopharma AD Stock Price History
Beta (5Y Monthly) | 0.092465 |
52-Week Change | 78.94% |
S&P500 52-Week Change | 20.43% |
52 Week High | 18.8 PLN |
52 Week Low | 8.85 PLN |
50-Day Moving Average | 13.4 PLN |
200-Day Moving Average | 11.07 PLN |
SPH.WA Share Statistics
Avg. Volume (3 month) | 583 PLN |
Avg. Daily Volume (10-Days) | 1.02K PLN |
Shares Outstanding | 121.32M |
Float | 41.83M |
Short Ratio | N/A |
% Held by Insiders | 57.11% |
% Held by Institutions | 5.48% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 4.83% |
Operating Margin (ttm) | 0% |
Gross Margin | 22.16% |
EBITDA Margin | 7.44% |
Management Effectiveness
Return on Assets (ttm) | 4.85% |
Return on Equity (ttm) | 12.44% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 17.59% |
Gross Profit (ttm) | 364.85M PLN |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | 1.84 |
Quarterly Earnings Growth (yoy) | 56.00% |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | 38.5 PLN |
Current Ratio (mrq) | 1.442 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Sopharma AD
Country | Poland |
State | N/A |
City | Sofia |
Address | 16 Iliensko shosse street |
ZIP | N/A |
Phone | 359 700 47474 |
Website | https://www.sopharmagroup.com |
Industry | Medical Distribution |
Sector(s) | Healthcare |
Full Time Employees | 4770 |
Sopharma AD researches and develops, produces, and trades in medicinal substances, finished drug forms, infusion medicine, and plastic medical disposable products for human and veterinary medicine, and food supplements in Bulgaria and internationally. It offers products in various therapeutic areas, such as cardiology, gastroenterology, pain management, cough and cold, immunology and dermatology, respiratory and asthma, neurology and psychiatry, urology, and gynecology. The company's products comprise Carsil to treat gastroenterological disorders; Tempalgin, an analgesic; Tabex, a plant-based drug used for smoking secession; Tribestan, a plant-based drug used for stimulation of the reproductive system; Broncholytin, which is used to suppress cough; Analgin, a generic analgesic; Nivalin, a plant-based product used for diseases of the peripheral nervous system; and Methylprednisolon, a general medicine for cases of severe allergies and life-threatening conditions. It also trades in food supplements; provides secondary packaging services for pharmaceutical products and real estate leases; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; and purchases, grows, produces, and trades in herbs and medicinal plants. In addition, the company engages in the retail trade of medicinal products and medical equipment; production of non-medicinal, and other products; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Further, it offers public opinion research services. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.
Q&A For Sopharma AD Stock
What is a current SPH.WA stock price?
Sopharma AD SPH.WA stock price today per share is 13.4 PLN.
How to purchase Sopharma AD stock?
You can buy SPH.WA shares on the Warsaw exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sopharma AD?
The stock symbol or ticker of Sopharma AD is SPH.WA.
Which industry does the Sopharma AD company belong to?
The Sopharma AD industry is Medical Distribution.
How many shares does Sopharma AD have in circulation?
The max supply of Sopharma AD shares is 159.11M.
What is Sopharma AD Price to Earnings Ratio (PE Ratio)?
Sopharma AD PE Ratio is 9.05405300 now.
What was Sopharma AD earnings per share over the trailing 12 months (TTM)?
Sopharma AD EPS is 1.48 PLN over the trailing 12 months.
Which sector does the Sopharma AD company belong to?
The Sopharma AD sector is Healthcare.